Morgan Stanley’s Pulmatrix PULM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-25
Closed -$44 7939
2024
Q1
$44 Sell
25
-25
-50% -$46 ﹤0.01% 7528
2023
Q4
$94 Buy
50
+25
+100% +$48 ﹤0.01% 7489
2023
Q3
$51 Hold
25
﹤0.01% 7481
2023
Q2
$67 Hold
25
﹤0.01% 7521
2023
Q1
$73 Hold
25
﹤0.01% 7590
2022
Q4
$97 Hold
25
﹤0.01% 7698
2022
Q3
$0 Sell
25
-290
-92% -$1.29K ﹤0.01% 7836
2022
Q2
$1K Sell
315
-68
-18% -$359 ﹤0.01% 7698
2022
Q1
$3K Buy
+383
New +$2.78K ﹤0.01% 7690
2021
Q4
Sell
-5,896
Closed -$80.6K 8078
2021
Q3
$94K Sell
5,896
-7,376
-56% -$123K ﹤0.01% 6416
2021
Q2
$276K Buy
13,272
+12,474
+1,563% +$253K ﹤0.01% 5852
2021
Q1
$22K Buy
798
+704
+749% +$21.6K ﹤0.01% 6690
2020
Q4
$2K Sell
94
-4
-4% -$95 ﹤0.01% 6899
2020
Q3
$2K Buy
+98
New +$2.5K ﹤0.01% 6585
2019
Q2
Sell
-162
Closed -$4K 6719
2019
Q1
$4K Buy
162
+160
+8,000% +$5.35K ﹤0.01% 6361
2018
Q4
$0 Hold
2
﹤0.01% 6701
2018
Q3
$0 Hold
2
﹤0.01% 6778
2018
Q2
$0 Hold
2
﹤0.01% 6727
2018
Q1
$0 Hold
2
﹤0.01% 6676
2017
Q4
$1K Hold
2
﹤0.01% 6501
2017
Q3
$1K Hold
2
﹤0.01% 6462
2017
Q2
$1K Sell
2
-9
-82% -$4.86K ﹤0.01% 6516
2017
Q1
$7K Buy
+11
New +$6.55K ﹤0.01% 6296
2016
Q3
Hold
0
6549
2016
Q2
Hold
0
6620
2016
Q1
Sell
-28
Closed -$16.5K 6676
2015
Q4
$24K Sell
28
-17
-38% -$15.4K ﹤0.01% 5981
2015
Q3
$44K Buy
+45
New +$56.7K ﹤0.01% 5783
2015
Q2
Sell
-16
Closed -$31K 6724
2015
Q1
$27K Sell
16
-26
-62% -$51.1K ﹤0.01% 5980
2014
Q4
$73K Buy
42
+17
+68% +$36.3K ﹤0.01% 5678
2014
Q3
$60K Sell
25
-45
-64% -$121K ﹤0.01% 5664
2014
Q2
$209K Buy
+70
New +$231K ﹤0.01% 5131

Other funds holding PULM

Morgan Stanley's PULM Position: Q2 2024 in Review

Morgan Stanley sold out of Pulmatrix (PULM) in Q2 2024, closing a stake of 25 shares — an estimated $44 sold.

Morgan Stanley first reported a position in PULM in Q2 2014 and held it in 29 quarters. The position peaked at $276K in Q2 2021. 12 funds tracked by Wall St. Rank hold PULM as of Q2 2024.

  • Morgan Stanley reported no remaining Pulmatrix position as of Q2 2024 after selling out during the quarter.
  • Morgan Stanley sold 25 Pulmatrix shares in Q2 2024, an estimated $44.
  • Morgan Stanley first reported a position in Pulmatrix in Q2 2014 and held it in 29 quarters.
  • Morgan Stanley's Pulmatrix position peaked at $276K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Pulmatrix as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.